Table 4.
Complications among the participants.
| All | Euglycaemia n (%) | Dysglycaemia n (%) | |||
|---|---|---|---|---|---|
| All | Hypoglycemia | Hyperglycemia | |||
| DIC | 9 (2) | 1 (0.5) | 8 (4)# | 3 (11) | 5 (3) |
| ARF | 17 (4) | 2 (1) | 15 (7)# | 4 (14) | 11 (6) |
| Shock | 39 (9) | 4 (2) | 35 (16)# | 6 (21) | 29 (16) |
| Hepatitis | 8 (2) | 2 (1) | 6 (2) | 0 (0) | 6 (3) |
| IVH | 28 (7) | 6 (3) | 22 (10)# | 0 (0) | 22 (12) |
| Other complications* | 27 (7) | 2 (2) | 25 (11)# | 3 (11) | 22 (12) |
DIC: disseminated intravascular coagulation; ARF: acute respiratory failure; IVH: intraventricular hemorrhage.
*“Other complications” include cortical blindness, hemiparesis, haemoglobinuria, heart failure, hypoglycaemia, intestinal perforation, and repeated convulsions.
# P < 0.05 compared to corresponding group with euglycemia.
Data are given as n (%). % reflects the percentage of complications in all subjects (n = 430), in subjects with euglycemia (n = 215) and in subjects with dysglycemia (all (n = 215), hypoglycemia (n = 28), or hyperglycemia (n = 187)). There were 128 complications in 116 subjects.